Insider · CIK 0001419579

Duliege Anne-Marie

Reports to the SEC for 3 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001419579

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-03-20	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Medical Officer	AAward	+75K sh	—	—	75,000
2019-01-23	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Medical Officer	AAward	+163K sh	—	—	162,500
2018-09-17	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−116K sh	$3.50	−$404K	0
2018-09-17	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−37.5K sh	—	—	112,500
2018-09-17	RIGLRIGEL PHARMACEUTICALS INC · Employe Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−116K sh	—	—	268,000
2018-09-17	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+37.5K sh	$2.11	+$79.1K	37,500
2018-09-17	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−37.5K sh	$3.50	−$131K	0
2018-09-17	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+116K sh	$2.54	+$293K	115,500
2018-09-04	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−16.5K sh	$3.51	−$57.9K	0
2018-09-04	RIGLRIGEL PHARMACEUTICALS INCM Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	+16.5K sh	$2.54	+$41.9K	16,500
2018-09-04	RIGLRIGEL PHARMACEUTICALS INC · Employe Stock Option (right to buy)M Exercise/Conversion	EVP & Chief Medical Officer	MExercise/Conversion	−16.5K sh	—	—	383,500
2018-07-02	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$2.79	−$13.9K	0
2018-05-09	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+150K sh	—	—	150,000
2018-04-20	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$4.11	−$20.6K	0
2018-01-24	RIGLRIGEL PHARMACEUTICALS INC · Employee Stock Option (right to buy)A Award	EVP & Chief Medical Officer	AAward	+150K sh	—	—	150,000
2017-07-05	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$2.69	−$13.4K	0
2017-02-02	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+150K sh	—	—	150,000
2017-01-03	RIGLRIGEL PHARMACEUTICALS INCS Sale	EVP & Chief Medical Officer	SSale	−5,000 sh	$2.41	−$12K	0
2016-05-05	RIGLRIGEL PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP & Chief Medical Officer	AAward	+400K sh	—	—	400,000
2014-11-18	ChemoCentryx, Inc.S Sale	EVP, Chief of Strategic Dev.	SSale	−4,970 sh	$4.71	−$23.4K	0
2014-03-26	ChemoCentryx, Inc.Stock Option (right to buy)A Award	EVP, Chief of Strategic Dev.	AAward	+335K sh	—	—	335,000
2013-01-30	AFFYMAX INCA Award	Chief Medical Officer	AAward	+5,000 sh	—	—	28,125
2013-01-30	AFFYMAX INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2013-01-30	AFFYMAX INCResticted Stock UnitA Award	Chief Medical Officer	AAward	+10K sh	—	—	10,000
2012-11-01	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−1,056 sh	$22.90	−$24.2K	23,125
2012-10-10	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−9,704 sh	$24.00	−$233K	23,125
2012-09-13	AFFYMAX INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,061 sh	—	—	44,689
2012-09-13	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,500 sh	$4.36	+$10.9K	35,329
2012-09-13	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+16.7K sh	$5.83	+$97.2K	51,995
2012-09-13	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,061 sh	$7.99	+$32.4K	56,056
2012-09-13	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−23.2K sh	$20.00	−$465K	32,829
2012-09-13	AFFYMAX INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,500 sh	—	—	0
2012-09-13	AFFYMAX INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−16.7K sh	—	—	23,334
2012-05-25	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−3,689 sh	$14.11	−$52.1K	32,829
2012-01-31	AFFYMAX INCA Award	Chief Medical Officer	AAward	+8,125 sh	—	—	32,829
2012-01-31	AFFYMAX INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+48.8K sh	—	—	48,750
2011-11-01	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−823 sh	$5.17	−$4,254.91	24,704
2011-08-17	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−5,296 sh	$4.73	−$25.1K	24,704
2011-06-23	AFFYMAX INCS Sale	Chief Medical Officer	SSale	+4,023 sh	$6.47	+$26K	30,000
2010-09-22	AFFYMAX INCA Award	Chief Medical Officer	AAward	+30K sh	—	—	30,000
2010-09-22	AFFYMAX INCStock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+40K sh	—	—	40,000
2010-05-04	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,500 sh	$4.36	+$10.9K	4,197
2010-05-04	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−4,197 sh	$24.07	−$101K	0
2010-05-04	AFFYMAX INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,500 sh	—	—	2,500
2010-03-16	AFFYMAX INCStock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,500 sh	—	—	0
2010-03-16	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,500 sh	$0.80	+$2,000	2,500
2010-03-16	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−2,500 sh	$20.96	−$52.4K	0
2010-03-15	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+5,000 sh	$4.36	+$21.8K	10,500
2010-03-15	AFFYMAX INCM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+11.1K sh	$10.99	+$122K	21,583
2010-03-15	AFFYMAX INCS Sale	Chief Medical Officer	SSale	−21.6K sh	$20.88	−$451K	0

Recent filings

Accepted (ET)
Mar 224
Duliege Anne-Marie0001179110-19-004206
SEC(opens sec.gov)
Jan 254
Duliege Anne-Marie0001179110-19-000933
SEC(opens sec.gov)
Sep 194
Duliege Anne-Marie0001179110-18-011567
SEC(opens sec.gov)
Sep 64
Duliege Anne-Marie0001179110-18-011179
SEC(opens sec.gov)
Jul 54
Duliege Anne-Marie0001179110-18-009506
SEC(opens sec.gov)
May 114
Duliege Anne-Marie0001179110-18-006678
SEC(opens sec.gov)
Apr 244
Duliege Anne-Marie0001179110-18-005850
SEC(opens sec.gov)
Jan 264
Duliege Anne-Marie0001179110-18-001142
SEC(opens sec.gov)
Jul 74
RIGEL PHARMACEUTICALS INC0001179110-17-010231
SEC(opens sec.gov)
Feb 64
RIGEL PHARMACEUTICALS INC0001179110-17-001818
SEC(opens sec.gov)
Jan 134
RIGEL PHARMACEUTICALS INC0001179110-17-000942
SEC(opens sec.gov)
May 94
RIGEL PHARMACEUTICALS INC0001179110-16-024208
SEC(opens sec.gov)
Nov 204
ChemoCentryx, Inc.0001209191-14-070483
SEC(opens sec.gov)

Companies

Address

C/O AFFYMAX, INC. 4001 MIRANDA AVE.

PALO ALTO, CA, 94304